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Development of effective (trans)dermal drug delivery systems requires reliable skin 
models to evaluate skin drug penetration. The isolated perfused human skin flap 
remains metabolically active tissue for up to 6 hours during in vitro perfusion. We 
introduce the isolated perfused human skin flap as a close-to-in vivo skin penetration 
model. To validate the model’s ability to evaluate skin drug penetration the solutions 
of a hydrophilic (calcein) and a lipophilic (rhodamine) fluorescence marker were 
applied. The skin flaps were perfused with modified Krebs-Henseleit buffer (pH 7.4). 
Infrared technology was used to monitor perfusion and to select a well-perfused skin 
area for administration of the markers. Flap perfusion and physiological parameters 
were maintained constant during the 6 hours experiments and the amount of markers 
in the perfusate was determined. Calcein was detected in the perfusate, whereas 
rhodamine was not detectable. Confocal images of skin cross-sections shoved that 
calcein was uniformly distributed through the skin, whereas rhodamine accumulated 
in the stratum corneum. For comparison, the penetration of both markers was 
evaluated on ex vivo human skin, pig skin and cellophane membrane. The proposed 
perfused flap model enabled us to distinguish between the penetrations of the two 
markers and could be a promising close-to-in vivo tool in skin penetration studies and 
optimization of formulations destined for skin administration. 
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(Trans)dermal delivery of drugs and cosmeceuticals has gained increasing interest in 
pharmaceutical and cosmetic fields. The skin represents an attractive route of drug 
delivery for both local and systemic effects. In this context, investigating the drug 
penetration into/through the skin is of fundamental importance regarding both the 
desired drug’s therapeutic efficacy and its potential toxicity (DeLouise, 2012; Prow et 
al., 2011). Skin, especially the stratum corneum (SC) layer, exhibits very efficient 
barrier properties which limit drug penetration into/through the skin and needs to be 
overcome for successful trans(dermal) delivery (Bouwstra et al., 2003; Lane, 2013).  
Therefore, reliable skin models able to predict and evaluate the (desired or undesired) 
penetration of molecules/nanosystems in vivo and serve as a tool in optimization of 
topical formulations are required (Flaten et al., 2015). In vivo studies, especially in 
humans, are the golden standard tool in skin penetration studies. However, in the early 
stages of drug development, in vivo studies are restricted due to ethical and 
economical concerns (Parra et al., 2016). Moreover, new regulations limit the use of 
animals for in vivo studies in the initial stages of product development (Flaten et al., 
2015). Therefore, in vitro and ex vivo techniques are gaining more interest as tools to 
study skin penetration (Patel et al., 2016).  
The skin perfusion models comprise a surgically prepared portion of skin (flap) 
including subcutaneous fatty tissue with assured continuous vascular circulation. 
These models offer the benefits of living metabolically-active tissue and are 
considered the missing link between in vitro and in vivo methods (Schaefer et al., 
2008). These models overcome some of the limitations of the in vitro studies using 
human or animal skin, such as the use of only epidermis and the upper part of the 
dermis and the lack of a dermal vascular system (de Lange et al., 1992; Patel et al., 
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2016). Several animal specimens have been used for the skin perfusion model, such as 
the isolated perfused pig skin flap (Riviere et al., 1986), the isolated blood-perfused 
pig ear (de Lange et al., 1992), the isolated perfused bovine udder (Kietzmann et al., 
1993) and the pig forelimb (Wagner et al., 2003). Several animal skin perfusion 
models are in use (Riviere et al., 1986; de Lange et al., 1992; Kietzmann et al., 1993; 
Wagner et al., 2003); however, their use retains the limitations of correlations between 
animal and human skin. Pig skin is considered the most suitable animal model to 
mimic human skin. Therefore, pig skin flap has been widely studied as skin perfusion 
model and skin penetration of different substances has been investigated using the 
isolated perfused pig skin flap model (Carver et al., 1989; Carver et al., 1990; 
Williams et al., 1990; Wester et al., 1998; Inman et al., 2003).  
However, use of animal skin retains the limitations of correlations between animal 
and human skin. Kreidstein et al. (1991) designed the isolated perfused human skin 
flap model using transverse paraumbilical skin flap. This tissue is normally discarded 
in abdominal dermolipectomy (Kreidstein et al., 1991). Several techniques have 
confirmed the perfusion of the flap (Black et al., 2001; Kreidstein et al., 1995; Lipa et 
al., 1999; Miland et al., 2008). Miland and colleagues (2008) confirmed the suitability 
of the dynamic infrared thermography (DIRT) to monitor skin flap perfusion and to 
differentiate between well and less perfused areas.  
To the best of our knowledge, the isolated perfused human skin flap (IPHSF) has not 
been used to study (trans)dermal penetration. Such a model could be a valuable tool in 
skin penetration studies and in optimization of dosage forms/delivery systems for skin 
therapy. 
This study evaluated the feasibility of the IPHSF as a skin penetration model. To 
validate the IPHSF model, two fluorescent markers, a hydrophilic (calcein) and a 
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lipophilic (rhodamine), were used and their penetration investigated over a 6 hours 
period. Confocal laser scanner microscopy (CLSM) technique was used to follow the 
fluorescent markers penetration through the IPHSF. These data were compared with 
the ex vivo (human and pig skin) and in vitro (cellophane membrane) penetration 
studies in Franz diffusion cells (FDC).  
 
2. Material and methods 
2.1. Material 
Calcein, rhodamine B, sodium chloride, potassium chloride, magnesium sulfate, 
sodium bicarbonate, trichloroacetic acid ( ≥99.0 %), ethanol (96 %, v/v) and TritonTM 
X-100 were from Sigma-Aldrich Chemie (Steinheim, Germany); human serum 
albumin (30 mg/mL) from Octapharma AG (Lachen, Switzerland); propylene glycol 
(PG) from NMD – Norwegian Medical Depot AS (Oslo, Norway) and glucose, 
calcium chloride and potassium dihydrogen phosphate from Merck KGaA 
(Darmstadt, Germany). Sucrose was product of VWR International bvba/sprl 
(Leuven, Belgium). Pig ears were purchased from Nurtura AS (Bardufoss, Norway). 
 
2.2. Human skin flap   
Eight human skin flaps were used in this study and were obtained from the abdomen 
of female patients (mean age 49.5 years, range 40-66 years) who underwent 
abdominoplasty (Table 1). All patients gave their written consent prior to the surgery 
and the experiments were performed according to the Declaration of Helsinki 
Principles. Since these skin panni are normally disposed of by incineration, no ethical 
approval for their use was required according to Norwegian Ethical Committee. The 
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procurement and disposal of human skin flaps were in accordance with the policy of 
the University Hospital of North Norway, Tromsø.  
 
2.3. Preliminary perfusion experiment  
A modification of the perfusion design of the model described by Miland and co-
workers (2008) was used. The human skin flap, after its excision, was wrapped in 
gauze soaked with physiological solution and placed in a sealed plastic box to 
maintain it at room temperature until it was transferred in the laboratory where the 
flap experiments were performed. To perfuse the human skin flap, it was placed on a 
metal grid and one vessel was selected and cannulated with an arteriotomy cannula 
(diameter 1 mm; DLP® Metronic Inc, Minneapolis, USA), which was then connected 
to the perfusion apparatus (Figure 1). The cannulation was performed at room 
temperature. The perfusate was modified Krebs-Henseleit buffer (KHb) comprising 
(in mM): 110 NaCl, 3.8 KCl, 1.4 KH2PO4, 1.2 MgSO4, 31 NaHCO3, 2.5 CaCl2, 11 
glucose and 10 sucrose. Human serum albumin (30 mg/ml) was added to the 
perfusate. The perfusate had a pH of 7.4 and an osmolarity of 290 mOsm mimicking 
the physiological conditions.  
The perfusion flow rate (6-8 mL/min) was monitored using a drop counter and the 
pressure by inline pressure transducer (Transpac® IV; Abbott Laboratories, North 
Chicago, IL, USA).  
All perfusions were initiated within 90 min after the excision of skin panni (Miland et 
al., 2008). 
2.4. Validation of the IPHSF model 
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Preliminary calcein skin penetration experiments through the IPHSF were performed 
to validate the experimental setups and the analytical method of the quantification of 
penetrated marker in the perfusate. Calcein solution (10 mM) in KHb was applied 
onto the perfused skin flap (Figure 1). The skin diffusion area (49 cm2) exhibiting best 
perfusion (skin temperature of ca. 32 ºC) was measured with an IR camera (FLIR 
ThermaCAM S65 HS, FLIR Systems). An adhesive patch constituted the donor 
chamber and calcein solution (7 mL) was applied onto the selected well-perfused skin 
area using a syringe. The experiment was carried out for 6 h when no leakage of the 
solution was observed. The weight of the flap was determined before and after the 
perfusion period. The penetrated calcein was assessed spectrofluorometrically 
spectrophotometrically in the perfusate collected after 6 h from a metal container 
placed under the flap. To assure that no inherent fluorescent skin constituents were 
detected, the perfusate was also collected when calcein solution was applied (time 0). 
Moreover, the non-penetrated calcein (retained on the flap surface) was swept and 
quantified at the end of experiment.  
Figure 1. 
 
2.4.1. Quantification of calcein in the perfusate 
The analytical method used to detect and quantify calcein in the perfusate was based 
on Bahia and co-workers (2010) with modifications. The collected perfusate was 
centrifuged to remove blood cells (1914 g, 20 min). To assure that no calcein 
precipitated with the blood cells the pellets were firstly washed with KHb (10 mL) 
and secondly dissolved in Triton solution 5% (w/v; 10 mL). Trichloroacetic acid 
(58.82%, w/v) was used to precipitate plasma protein. Calcein concentrations in the 
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supernatants, pellets washed after blood cells precipitation and pellets dissolved in 
Triton solution were determined spectrofluorometrically spectrophotometrically 
(excitation and emission wavelengths at 485 and 520 nm, respectively) on a Polarstar 
fluorimeter (Fluostar; BMG Technologies, Offenburg, Germany) using a multiplate 
reader (COSTAR 96). Three parallels were determined for each sample. Equation 1 
(derived from the Fick's first law) was used to calculate the apparent permeability 
coefficient (Papp) where J is the observed flux rate (μg/cm2/s) and Cd is the 
concentration of calcein solution in the patch (μg/mL). The flux was calculated from 
the linear part of the curve, representing the steady-state condition. 
Papp (cm/s) = J / Cd                        (1) 
 
 
2.5. Skin penetration experiments on IPHSF model 
Calcein (10 mM) in KHb and rhodamine (10 mM) in KHb/PG (0.5%, v/v) were 
applied onto the perfused skin flaps perfused with KHb (Figure 1). The weight and 
thickness of each flap were determined before and at the end of the experiment. The 
perfusate was collected at time 0 and every hour for a period of 6 h and sink 
conditions were maintained. The penetrated and non-penetrated markers were 
quantified as described in the methods for validation of the IPHSF model. 
 
2.6. Confocal laser scanning microscopy (CLSM)  
CLSM analysis was performed on a Leica TCS SP5 microscope (Leica Microsystems 
CMS GmbH, Mannheim, Germany) equipped with an Argon laser. The samples were 
prepared using the imprint method (Brommeland et al., 2003). A cross-sectioned slide 
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of the flap was cut by a scalpel and attached onto a microscope slide. The cells 
remaining on the slide were fixed in formalin (SPRAYFIX®, Histolab Products AB, 
Gothenburg, Sweden). The flap areas used in CLSM are shown in Figure 2a. Calcein 
and rhodamine were excited using 488 and 568 nm laser lines, respectively. 
Fluorescence was detected using the following spectral range: 5050-550 nm for 
calcein, 570-610 nm for rhodamine. When required, images were acquired in Z-
sections of 1 to 100 µm thickness and were superimposed. 
 
2.7. Ex vivo and in vitro skin penetration experiments 
Ex vivo and in vitro skin penetration experiments were carried out on Franz diffusion 
cells (FDC; PermeGear, Bethlehem, USA) of 1.77 cm2 diffusion area and with 12 mL 
receiver volume (Hurler et al., 2012). Ex vivo skin penetration experiments were 
performed using human skin (HS) and pig ear skin (PS). Human skin (HS) was 
obtained from human skin flaps, which were not the same as the flaps used in skin 
penetration experiments on IPHSF model (Table 1). and pig ear skin (PS) were used 
in ex vivo skin penetration experiments, while Ccellophane membrane (CM; Max 
Bringmann KG, Wendelstein, Germany) was employed in in vitro experiments. The 
same solutions of the fluorescent markers tested in the IPHSF were added into the 
donor chamber (600 µL). The receiver chamber was filled with KHb. Samples (500 
μL) were collected at 1, 2, 4 and 6 h and replaced by fresh acceptor medium to 
maintain sink conditions. All experiments were carried out at 32 °C. Calcein and 
rhodamine concentrations were determined  





2.8. Statistical evaluation 
The Student's t-test was used for the comparison of two means. A significance level of 




Any model destined for application in the development and optimization of skin 
formulations needs to be validated to confirm its robustness and wider applicability.  
 
3.1. Validation of IPHSF model 
Table 1 provides an overview of the characteristics of the flaps used in experiments. 
The perfusion experimental set up of Miland et al. (2008) was modified to identify the 
areas of the flap with skin temperature of at least 32 ºC corresponding to adequate 
perfusion (Figure 1). This enabled us to establish the area (49 cm2) of well-perfused 
skin surface suitable to apply fluorescent markers. Once the area was selected, we 
focused on optimizing the volume (mL) of the marker solution to be applied. A 
fluorescent marker cCalcein solution (7 mL) was injected into an adhesive patch 
(donor chamber) attached to the selected well-perfused skin area and penetration 




The IPHSF was further validated in respect to possible oedema formation and the 
weight changes. Variation of less than 10 % in the weight observed during 6 h of 
perfusion was found acceptable (data not shown).  
 
Calcein was detected in the perfusate. Moreover, in the perfusate collected at time 0 
no fluorescence was detected, indicating that no inherent fluorescent skin constituents 
were present in the perfusate and could be detected spectrofluorometrically.   
 
3.2. Assuring perfusion during the skin penetration studies  
Physiological parameters were monitored throughout the experiment. The flow, 
perfusion pressure and inlet temperature were kept constant during 6 h (Table 2).  
Table 2. 
Figure 2. 
All areas where the markers were applied were well perfused throughout the 
experiment and no leakage of markers from the donor chambers were observed 
(Figure 2a). DIRT images, taken 1 min after the start of the perfusion, showed a hot 
spot indicating where the skin perfusion started (Figure 2b). A distinct area of 
rewarming appeared corresponding to the perfusion area of the cannulated vessel. 
DIRT images were also taken before and after the application of markers (Figure 2c) 
and confirmed well-perfused skin in areas where the markers were applied throughout 
the experiment (Figure 2d, e).  
 
3.3. Penetration of fluorescent markers in IPHSF model 
13 
 
DIRT images of flap areas where markers were applied showed that the area was still 
perfused after 6 h. Interestingly, DIRT images of flap areas next to where rhodamine 
was applied showed also the less well-perfused area (skin surface temperature lower 
than 32 ºC) (Figure 2e). To further investigate this area, a cross-section of the area 
was analyzed by CLSM. CLSM images of the marker-free skin area showed no 
presence of both markers, as expected (Figure 3a). CLSM images of calcein (green) in 
the perfused-treated area indicated a uniformly distributed fluorescence through the 
skin flap, while rhodamine (red) exhibited a bright fluorescence in the SC but 
decreasing fluorescence in the viable epidermis and subcutaneous fat tissue (Figure 
3b). CLSM images of both markers in the well-perfused-untreated area indicated a 
weaker fluorescence as compared to the treated area (Figure 3c). In the less well-
perfused areas we could only detect a weak fluorescence of rhodamine (Figure 3d).   
Figure 3.  
CLSM images confirmed the skin penetration profiles of the two markers in the 
IPHSF model.  
 
3.4. Correlation between the skin penetration in the IPHSF model and ex vivo 
and in vitro studies 
Penetration of two markers through IPHSF model is presented in Figure 4a. No 
fluorescence was detected in the perfusate at time 0, assuring that no inherent skin 
constituents were detected with our analytical method employed to quantify the 
penetrated markers in the perfusate. Calcein was detected in the perfusate, whereas 
rhodamine was not detectable. Ex vivo skin penetration studies using human skin 
revealed lower calcein penetration as compared to IPHSF (p<0.05) (Figure 4b). The 
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same penetration profiles of rhodamine were observed both in the IPHSF and in ex 
vivo studies on human skin (Figure 4a, b). More calcein and rhodamine penetrated 
through the pig skin and cellophane membrane compared to the ex vivo human skin 
and the IPHSF (Figure 4c, d). Calcein exhibited higher flux and Papp than rhodamine; 





The organization of the lipid domains in the SC is considered the main contributor to 
the barrier property of the skin (Bouwstra et al., 2003; Schmieder et al., 2015). This 
barrier property of the skin can be seen as a synergy between the cooperation and 
interactions between SC macro- and micro-structure, bi- and three-dimensional 
supramolecular organization of the lipid matrix and composition of the SC (Baroli, 
2010). However, dermal circulation is responsible for the clearance of the drug from 
the skin and should not be neglected (Lane, 2013). The introduction of nanocarriers 
has opened a means to improve penetration of drug into/through the skin. 
Nanoparticles are expected to enhance or limit the ingress and diffusion of drugs 
into/through the skin depending on their physicochemical properties, particularly size 
(Vanić et al., 2015). Penetration of molecules and particles in and through skin is 
gaining increased attention due to increased focus on the transdermal therapies, safety 
of cosmetic products, possible penetration of environmental compounds and skin 
decontamination (Bolzinger et al., 2012).  
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Consequently, there is an increasing need to understand the penetration into/through 
the skin and the interaction between the carrier, drug and the skin not only to optimize 
the therapeutic applications, but also to minimize potential side effects (Bolzinger et 
al., 2012; DeLouise, 2012). However, reliable skin models able to predict and 
investigate desired or undesired penetration through the skin remain challenging. 
Human skin perfusion models offer the benefits of living tissue with active 
microcirculation, mimicking the application in human to a greater extent (Schaefer et 
al., 2008; Patel et al., 2016). Moreover, they provide a mean to study the effects of 
dermal vasculature on the systemic absorption. However, no human skin perfusion 
model has been used to assess the penetration of drugs/markers into the skin and as a 
tool in dermatological product development. Kreidstein and co-workers (1991) have 
shown that the human skin flap is metabolically and physiologically stable for at least 
5 h of in vitro perfusion. We used DIRT to measure skin perfusion. A number of 
studies have shown a good correlation between skin temperature and skin perfusion. 
As such DIRT can provide us indirectly with information on skin perfusion and its 
dynamics. (de Weerd et al., 2006; de Weerd et al., 2009).  
The perfusion of IPHSF was performed using the established method by Miland et al. 
(2008) with modifications. To validate the model, preliminary skin penetration studies 
were performed on perfused skin flaps in order to establish the experimental design of 
skin penetration studies on IPHSF. In both preliminary and skin penetration studies, 
In all flaps we observed the same dynamics of perfusion. This confirmed that 
experimental conditions remained constant throughout the experiments. Moreover, 
little variation (less than 10 %) in the weight and thickness of all flaps during 6 h 
perfusion excluded oedema formation and assured a good tissue perfusion as reported 
earlier (Black et al., 2001; de Lange et al., 1992; Lipa et al., 1999). Similar to Miland 
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et al. (2008) a perfusion flow rate between 6 and 8 ml/min was maintained during the 
experiments. The perfusion pressure was higher than 50 mmHg, which we attribute to 
the smaller cannula diameter and the different software used to monitor the baseline 
perfusion in our experiments as compared to Miland et al. (2008).  
 
The IPHSF model was able to distinguish between the penetrations of two markers 
(0.7% calcein and 0% rhodamine). Calcein penetrated to a lower extent, as expected, 
since it is a hydrophilic marker with low logP (-5.02) (Gillet et al., 2011) with limited 
skin penetration potential (Bolzinger et al., 2012). Interestingly, calcein was detected 
in the perfusate, which would suggest that the circulation enabled its penetration. 
Rhodamine has a higher logP (1.95) (Anissimov et al., 2012) and due to its 
lipophilicity was prepared in solution containing PG (0.5 %; v/v) as a solubilizing 
agent. Therefore, we expected that PG would act as a penetration enhancer (Lane, 
2013). However, the concentration of PG used in our study was relatively low 
compared to the PG concentration used in other studies suggesting its role as 
penetration enhancer (Trottet et al., 2004; Watkinson et al., 2009). Similar penetration 
results were reported by Wester and co-workers (1998) and their studies on the 
isolated perfused pig skin flap model. Tested compounds with lower logP were 
detected in higher percentage in the perfusate compared to compounds with higher 
logP. Although we could not detect rhodamine in the perfusate, the amount of 
rhodamine retained at the administration site on the flap was less than calcein. This 
suggests that rhodamine remained within SC rather than penetrating deeper into 
epidermis, as expected (Bolzinger et al., 2012). The lipids in human skin barrier are 
organized as stacked bilayers of fully extended ceramides with cholesterol molecules 
associated with the ceramide sphingoid moiety, providing barrier towards both 
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hydrophilic and lipophilic molecules (Iwai et al., 2012). The extracellular space in SC 
and stratum granulosum exhibits hydrophobic properties due to its lipid-rich 
composition, whereas the layers below the stratum granulosum represent hydrophilic 
environment due to desmosome-rich composition (Iwai et al., 2012; Schmieder et al., 
2015). The IPHSF results were supported by the CLSM images of the cross-section of 
skin flaps. While calcein was found uniformly distributed throughout the flap, 
rhodamine exhibited a bright fluorescence in the SC but weaker fluorescence in the 
viable epidermis and subcutaneous fat tissue. Gillet and co-workers (2011) reported 
similar accumulation of rhodamine in the SC and negligent amount within the 
epidermis. The same penetration profile of rhodamine observed in the IPHSF model 
was seen in full human skin in FDC. Water present on the surface of skin might cause 
swelling of the polar head-group regions in the lipid bilayers, and hence disruption of 
the lipid domains, which could explain the higher fluxes of hydrophilic molecules 
such as calcein (Bolzinger et al., 2012). However, the percentage of penetrated calcein 
through full human skin in FDC was significantly lower (p<0.05) than through the 
IPHSF model indicating that the perfusion might play an important role in the 
penetration of compounds through the skin, as recently suggested by Patel et al. 
(2016). For the hydrophilic marker calcein we observed a positive effect of perfusion 
on its skin penetration, whereas for the lipophilic marker rhodamine the penetration 
profile was not influenced by the perfusion to a greater extent. 
These results support considerations that ex vivo skin studies do not resemble the in 
vivo situations to a satisfactory extent. This is a clear advantage of the skin perfusion 
models, since these models investigate the drug penetration considering also the 
dermal perfusion (Schaefer et al., 2008). Wagner and co-workers (2002) also reported 
that hydrophobic flufenamic acid penetrated less through the human skin in FDC 
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system than in in vivo studies. We confirmed that the perfusion played a role in the 
penetration of both markers by analyzing cross-section of perfused skin flap areas 
where the markers were not applied (as visible by DIRT images). CLSM images of 
these untreated perfused areas showed the presence of both markers in the skin and 
subcutaneous tissue of untreated areas confirming that perfusion affected the 
penetration. Such findings stress the importance of perfusion in a skin penetration 
model. 
The results obtained with the IPHSF model were compared with the results obtained 
on the established skin models. Both penetration studies through the pig skin and 
cellophane membrane showed a higher penetration of the markers compared to their 
penetration through the IPHSF model and human skin in FDC system, strongly 
indicating the importance of having a model that contains human skin. Interestingly, 
calcein penetrated through pig skin more than rhodamine. Observed Papp of calcein 
across pig skin was similar as in an established in vitro model mimicking human SC 
lipid composition (Engesland et al., 2013). Rhodamine penetration through the pig 
skin, IPHSF model and human skin on FDC system was similar and as expected since 
it is known that pig skin mimics human skin better for the lipophilic penetrants (Dick 
and Scott, 1992). Penetration of both markers through cellophane membrane was 
significantly higher than in other models used in this study (p<0.05); calcein 
penetrated more than rhodamine in agreement with Ansari and co-workers (2006) 
who tested the penetration of three drugs with different lipophilicity through human 
skin, cellophane and natural membranes. They found that penetration of water soluble 
diclofenac sodium through cellophane was higher than through all other membranes, 




Although different in vitro and ex vivo animal skin models help us to simplify the 
drug penetration, the results obtained from those models differ from the results 
obtained with IPHSF model suggesting the importance of this missing link in reaching 
the close-to-in vivo situation. 
The limitation of this study is the relatively small number of experiments; therefore, 
the results should be interpreted within the context of this limitation. Moreover, the 
IPHSF model is metabolically active for 6 h and skin drug penetration studies on 
IPHSF model have to be performed within this time limit. Specific equipment, such as 
infrared camera, is  needed to perform skin flap experiments as well as the help of 
selected professionals to cannulate the skin flap. Therefore, we are aware that the 
IPHSF model cannot be used as skin perfusion model in the early stages of drug 
development. However, the model might be used, after the fully validated 
methodologies have been employed, to study skin drug penetration in conditions 
closer to the in vivo human ones since However, the importance of perfusion and the 
use of human skin in skin penetration studies is clear. 
The next step in full utilization of the proposed model is to evaluate the penetration of 
nanoparticles and nanoparticle-associated drugs. 
 
5. Conclusions 
We demonstrated that the isolated perfused human skin flap model can be used in the 
skin penetration studies since it provides constant experimental conditions and 
perfusion, assuring reproducible results. Moreover, the model proves the benefits of 
working with living tissue using a byproduct of surgery, and avoiding animal use. The 
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model was able to distinguish between the penetrations of two markers and is a 
promising tool in optimization of formulations destined for skin administration.  
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Figures and figure legends: 
 
Figure 1. Flap perfusion design 
The perfusate was filtered and gassed with 95% O2/5% CO2 using a rotating surface 
oxygenator. The perfusion flow rate (6-8 mL/min) was monitored using a drop 
counter and the perfusion pressure measured with an inline pressure transducer. A 
heating circulator was set at 38 ºC and a thermocouple inserted in the cannula to 
monitor the temperature of the perfusate entering the flap. The IR camera monitored 
the skin surface temperature throughout the perfusion period. The flow, pressure and 
temperature of the perfusate were monitored on-line using PhysAcq software. The 
perfusate from IPHSF was collected using a metal container. 
 
Figure 2. Photographs and DIRT images of representative flaps in skin 
penetration experiments  
The a represents the photographs of flaps. The b are DIRT images recorded 1 min 
after the start of the perfusion (skin temperature below 32 ºC). The c, d and e are 
DIRT images recorded at time 0, 3 and 6 hours after the application of the markers, 
respectively (skin temperature at ca. 32 ºC).  
 
Figure 3. Representative CLSM images of cross-sections of IPHSF at the end of 
skin penetration experiments   
CLSM images of calcein (green fluorescence) in IPHSF are shown in the left column, 
while CLSM images of rhodamine (red fluorescence) are shown in the right column. 
The a represents the intact flap cut before the perfusion (control). The b is treated 
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area; c untreated area. The d is a non-perfused area observed by DIRT in flap where 
rhodamine was applied.  
Cross-sectioned slides of IPHSF were cut starting from the skin surface (S; left side) 
to the subcutaneous fat (SF; right side). Scale bar represents 500 µm. 
 
Figure 4. Penetration profiles of calcein and rhodamine through IPHSF (a), HS 
(b), PS (c) and CM (d). 
The concentration of calcein in KHb and rhodamine in KHb/PG (0.5%, v/v) solutions 
was 10 mM. The penetration of both markers was investigated for a period of 6 h. All 
experiments were conducted in triplicates and the results are presented as mean ± SD. 
* p<0.05.    
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Tables and table legends: 
 
Table 1. Characteristics of human skin flaps 
a Weight and thickness of the flaps were not determined in the preliminary study used 
to validate the experimental design of the perfusion technique and experimental set 
up. 
b Thickness (cm) refers to the full skin obtained from the human skin flap. Weight 
was not determined since not relevant for ex vivo study. 
 
Table 2. Characteristics and physiological parameters of IPHSF recorded during 
6 h of experiment (mean ± SD) 
a Variation (%) calculated from weight and thickness measured before and after 
perfusion of flaps. 
 
 
Table 3. In vitro and ex vivo penetration of calcein and rhodamine (mean ± SD) 
a The amount retained at skin surface. 
b nd, flux and Papp were not determined because no penetrated rhodamine was 
detected.   
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